BigJeff yes the share price is much too low, for what is going on with this company BUT --

never underestimate the greed and power of the market makers. OTC stocks are terribly easy to manipulate, and biotechs in general tend to move in extreme pendulum swings between euphoria and fear, huge moves up and devastating moves down. For instance, look at this chart of GALE:

http://bigcharts.marketwatch.com/quickchart/q...amp;time=8

aiyee! hopefully, since I own some, it will go back up to those old highs 30% higher, which came on MUCH lesser news than this recent deal with TEVA. Sigh.

They WILL try to shake us out. They WILL NOT succeed.